A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors. But this strategy has been undermined by the tendency of T cells to tire out before finishing ...
Jul 23, 2026
0
22
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work ...
Jul 3, 2026
0
30
Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies.
Jun 25, 2026
0
6
Immune checkpoint inhibitors are a form of cancer immunotherapy successfully used to treat a wide range of cancers. However, these treatments can cause side effects including immune-related colitis, or inflammation of the ...
Jun 17, 2026
0
5
Researchers from National Taiwan University (NTU) and National Taiwan University Hospital (NTUH) have identified a promising way to reinvigorate the body's cancer-fighting immune cells by rewiring their metabolism, revealing ...
Jun 17, 2026
0
312
Mesothelioma deaths and diagnoses continue to rise in the United States despite decades of asbestos regulation and reduced industrial use, according to a new national analysis from Sylvester Comprehensive Cancer Center, part ...
Jun 11, 2026
0
6
A new Northwestern Medicine study suggests that a simple blood test could help identify which patients with head and neck cancer will be most likely to benefit from immunotherapy, according to a study published in the Journal ...
Jun 8, 2026
0
3
Long regarded as cells involved primarily in allergic responses and antiparasitic defense, eosinophils are now drawing increasing attention in oncology. A review article led by Marie Gilon, an oncology resident physician ...
May 28, 2026
0
5
A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly kidney cancer. In the new study, published in Cell Reports Medicine, researchers tested a novel ...
May 14, 2026
0
49
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.
May 13, 2026
0
17
